Emerging Growth Drivers in the Adrenal Cancer Diagnostics Market Landscape: Rising Cigarette Smoking Boost The Adrenal Cancer
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Adrenal Cancer Diagnostics Market Growth Performance Trended Historically, And What Lies Ahead?
In recent times, we have witnessed a significant growth in the market size of adrenal cancer diagnostics. The market, which is anticipated to increase from $140.35 billion in 2024 to $148.54 billion in 2025, is expected to progress at a compound annual growth rate (CAGR) of 5.8%. The expansion during the historical period can be ascribed to a rise in incidence and awareness, advancements in genetic and molecular testing, improvements in biopsy techniques, advancements in endocrine testing and the incorporation of artificial intelligence (AI).
The market size for adrenal cancer diagnostics is anticipated to record significant growth in the upcoming years, with a forecast value of$190.8 billion in 2029 and a compound annual growth rate (CAGR) of 6.5%. Factors contributing to this growth in the predicted period include the implementation of personalized medicine techniques, an increase in less intrusive procedures, the prevalence of telemedicine and remote consultations, advancement in liquid biopsy, and broader genetic counseling services. The forecast period also points to important trends such as regulatory endorsement for diagnostic innovations, the embracement of digital pathology, progress in imaging technologies, advancement in liquid biopsy, and genomic profiling aimed at precision medicine.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13242&type=smp
Which Primay Drivers Are Accelerating Growth in the Adrenal Cancer Diagnostics Market?
The adrenal cancer diagnostics market is anticipated to expand due to the increasing rate of cigarette smoking. In this context, cigarette smoking involves inhaling and exhaling the smoke produced from burning tobacco, a process that releases nicotine, an addictive alkaloid with both stimulating and tranquilizing psychoactive effects. Research has linked cigarette smoking to a higher likelihood of developing adrenal cancer, such as adrenal adenomas and adrenocortical carcinomas. The harmful substances (carcinogens) present in tobacco smoke have the potential to harm adrenal cells’ DNA, resulting in mutations that could lead to cancer. For example, Statistics Canada reported in July 2022 that compared to June 2021, the production of cigarettes had risen by 5.8%. Moreover, there was a 1.3% rise in the total number of cigarettes sold from May 2022, with a total of 1.4 billion sold in June 2022. Hence, the increasing prevalence of cigarette smoking is fuelling the expansion of the adrenal cancer diagnostics market.
Which Primary Segments of the Adrenal Cancer Diagnostics Market Are Driving Growth and Industry Transformations?
The adrenal cancer diagnosticsmarket covered in this report is segmented –
1) By Test: Magnetic Resonance Imaging (MRI); Computed Tomography (CT) Scan; X-ray; Positron Emission Tomography (PET) Scan; Biopsy
2) By Treatment: Surgery; Chemotherapy; Radiotherapy; Targeted Cancer Therapies; Other Treatments
3) By Tumor Type: Pheochromocytoma; Adrenal Cortical Carcinoma; Other Types
4) By End-User: Hospitals; Ambulatory Surgical Centers; Cancer Centers; Other End-Users
Subsegments:
1) By Magnetic Resonance Imaging (MRI): Contrast-Enhanced MRI; Functional MRI
2) By Computed Tomography (CT) Scan: Contrast-Enhanced CT; Abdomen And Pelvis CT Scans
3) By X-ray: Standard X-ray Imaging; Specialized X-ray Techniques
4) By Positron Emission Tomography (PET) Scan: PET-CT Combination Scans; Standalone PET Scans
5) By Biopsy: Fine Needle Aspiration Biopsy (FNA); Core Needle Biopsy; Surgical Biopsy
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=13242&type=smp
Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Adrenal Cancer Diagnostics Market?# Market?
North America was the largest region in the adrenal cancer diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adrenal cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Which Technological Trends Are Reshaping the Adrenal Cancer Diagnostics Industry Dynamics?
The leading companies in the adrenal cancer diagnostics market are pioneering unique projects with sophisticated collaboration frameworks, such as the CancerX Startup Accelerator, to promote digital progression in oncology care. The Accelerator’s goal is to offer budding startups mentorship, education, and direct communication with healthcare industry’s significant players, including providers and pharmaceutical corporations. For instance, CanceRx, LLC, a public-private partnership from the US formed to fuel innovation in the cancer battle, declared the kickoff of this project at the Future of Cancer Care Summit in Tampa, Florida in November 2023. The program is set to choose its first group of roughly 15 to 20 companies from March 2024, with an emphasis on key areas such as clinical research, screening, diagnosis, and treatment. It is projected to substantially promote the objectives of the Cancer Moonshot initiative by meeting unfulfilled demands in oncology care and encouraging the creation of effective digital health instruments in oncology.
View the full report here:
https://www.thebusinessresearchcompany.com/report/adrenal-cancer-diagnostics-global-market-report
What Parameters Are Used to Define the Adrenal Cancer Diagnostics Market?
Adrenal cancer diagnostics refers to the process of identifying and diagnosing adrenal cancer, which is cancer that originates in the adrenal glands located above the kidneys. This process involves a series of medical evaluations, tests, and procedures designed to determine whether a person has adrenal cancer. It is essential for effective treatment planning and management.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13242
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
